Showing results (1-10 of 208) with videos related to
Sort By:
Pageof 21
Trends in Molecular Medicine|July 11, 2020
Inflammasomes and Cell Death: Common Pathways in Microparticle DiseasesMaryam Rashidi, Ian P Wicks, James E VinceCurrent Opinion in Immunology|November 7, 2020
Necroptotic movers and shakers: cell types, inflammatory drivers and diseasesAshley Weir, Sebastian Hughes, Maryam Rashidi, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2019
The Pyroptotic Cell Death Effector Gasdermin D Is Activated by Gout-Associated Uric Acid Crystals but Is Dispensable for Cell Death and IL-1β ReleaseMaryam Rashidi, Daniel S Simpson, Anne Hempel, et al.Nature Reviews. Rheumatology|December 4, 2015
Targeting GM-CSF in inflammatory diseasesIan P Wicks, Andrew W RobertsJournal of Leukocyte Biology|January 24, 2013
Bcl-2 overexpression ameliorates immune complex-mediated arthritis by altering FcγRIIb expression and monocyte homeostasisKate E Lawlor, Annemarie van Nieuwenhuijze, Karen L Parker, et al.The Journal of Investigative Dermatology|July 16, 2015
When Beauty Is Skin Deep: Regulation of the Wound Response by Caspase-8, RIPK3, and the InflammasomeJames E VinceNature Reviews. Rheumatology|July 10, 2020
Cell death in chronic inflammation: breaking the cycle to treat rheumatic diseaseHolly Anderton, Ian P Wicks, John SilkeCurrent Pharmaceutical Design|March 12, 2015
Interleukin-6 in rheumatoid arthritis - from the laboratory to the bedsideXiao Liu, Andrew J Teichtahl, Ian P WicksNature Communications|February 19, 2015
RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKLKate E Lawlor, Nufail Khan, Alison Mildenhall, et al.Pageof 21